Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women

A Study of LXR015-1 in HIV-Infected Patients

NCT00002365 ·Status: COMPLETED ·Phase: PHASE1

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

NCT02165202 ·Status: COMPLETED ·Phase: PHASE2

Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents

NCT00485264 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

NCT00006444 ·Status: COMPLETED

A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection

NCT00001000 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644)

NCT05414786 ·Status: UNKNOWN ·Phase: PHASE1

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001041 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

NCT00002441 ·Status: COMPLETED ·Phase: PHASE3

Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T

NCT05529342 ·Status: ENROLLING_BY_INVITATION

Immune Responses in Patients Treated With Raltegravir

NCT00785967 ·Status: WITHDRAWN ·Phase: PHASE3

Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines

NCT00056745 ·Status: COMPLETED ·Phase: PHASE1

Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001046 ·Status: WITHDRAWN ·Phase: PHASE1

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

NCT01461096 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.

NCT06436274 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers

NCT00001992 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm

NCT00076817 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall Good Health in South Africa.

NCT06694753 ·Status: RECRUITING ·Phase: PHASE1

Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1

NCT03739996 ·Status: COMPLETED ·Phase: PHASE2

Oral Human Papillomavirus Infection in HIV-infected Men

NCT00421486 ·Status: UNKNOWN

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

NCT04925752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy

NCT05540964 ·Status: UNKNOWN

Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144

NCT01435135 ·Status: UNKNOWN ·Phase: PHASE2

Study of Anti-HIV Therapy Intensification

NCT00034086 ·Status: COMPLETED ·Phase: NA

A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers

NCT00851383 ·Status: COMPLETED ·Phase: PHASE1

Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein

NCT00529698 ·Status: COMPLETED ·Phase: PHASE1